Literature DB >> 18849918

Clinical significance of signet-ring cells in colorectal mucinous adenocarcinoma.

Chang Okh Sung1, Jin Won Seo, Kyoung-Mee Kim, In-Gu Do, Seon Woo Kim, Cheol-Keun Park.   

Abstract

Mucin occasionally accumulates intracellularly in colorectal mucinous adenocarcinomas, resulting in signet-ring cell morphology. In the current practice of pathology, there is no definitive rule on how to report a minor component of signet-ring cells in colorectal mucinous adenocarcinomas. We hypothesized that the absence of signet-ring cell component might have a favorable effect on survival of mucinous adenocarcinoma patients. To assess the biological characteristics of colorectal mucinous adenocarcinoma, we analyzed its clinicopathological features, microsatellite instability status, and survival outcomes and compared them with those of colorectal signet-ring cell carcinoma. A total of 266 consecutive colorectal mucinous adenocarcinoma patients and 65 signet-ring cell carcinoma patients were included. Mucinous adenocarcinomas, by comparison with signet-ring cell carcinomas, were characterized by development at an older age, less frequent vascular invasion and lymph node metastasis, and lower TNM stage at presentation. A total of 21 (22%) of 95 mucinous adenocarcinomas and 12 (19%) of 63 signet-ring cell carcinomas were high-frequency microsatellite instability. Patients with mucinous adenocarcinoma had significantly better survival than those with signet-ring cell carcinoma (P<0.0001) or than those with signet-ring cell carcinoma showing >50% extracellular mucin by volume (P<0.0001). In univariate analysis, absence of signet-ring cell component (P=0.0197), absence of vascular invasion, decreased invasion depth, no lymph node metastasis, and lower TNM stage had a favorable effect on survival of mucinous adenocarcinoma patients. Absence of vascular invasion, no lymph node metastasis, and lower TNM stage had a favorable effect on survival of signet-ring cell carcinoma patients. Multivariate analysis showed that higher TNM stage and T stage 4 were independent predictors of poor outcome in patients with mucinous adenocarcinoma. Our observations strongly suggest that pathologists should report the percentage of signet-ring cell component in colorectal mucinous adenocarcinomas and mucinous adenocarcinoma has different biologic behavior compared with signet-ring cell carcinoma.

Entities:  

Mesh:

Year:  2008        PMID: 18849918     DOI: 10.1038/modpathol.2008.170

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  39 in total

1.  Prognostic relevance of histopathological features in signet ring cell carcinoma of the colorectum.

Authors:  Valeria Barresi; Luca Reggiani Bonetti; Federica Domati; Luigi Baron
Journal:  Virchows Arch       Date:  2016-07-09       Impact factor: 4.064

2.  Correlation Between Clinical and Pathologic Staging in Colon Cancer: Implications for Neoadjuvant Treatment.

Authors:  Ahmed N Dehal; Amanda N Graff-Baker; Brooke Vuong; Daniel Nelson; Shu-Ching Chang; David Y Lee; Melanie Goldfarb; Anton J Bilchik
Journal:  J Gastrointest Surg       Date:  2018-05-22       Impact factor: 3.452

3.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

4.  Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.

Authors:  John R Hyngstrom; Chung-Yuan Hu; Yan Xing; Y Nancy You; Barry W Feig; John M Skibber; Miguel A Rodriguez-Bigas; Janice N Cormier; George J Chang
Journal:  Ann Surg Oncol       Date:  2012-04-04       Impact factor: 5.344

5.  Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.

Authors:  Kentaro Inamura; Mai Yamauchi; Reiko Nishihara; Sun A Kim; Curtis C Harris; Zhi Rong Qian; Shuji Ogino; Kosuke Mima; Yasutaka Sukawa; Tingting Li; Mika Yasunari; Xuehong Zhang; Kana Wu; Jeffrey A Meyerhardt; Charles S Fuchs
Journal:  Ann Surg Oncol       Date:  2014-10-18       Impact factor: 5.344

6.  Cancer as a metabolic disease.

Authors:  Thomas N Seyfried; Laura M Shelton
Journal:  Nutr Metab (Lond)       Date:  2010-01-27       Impact factor: 4.169

7.  Clinicopathological features and survival outcomes of primary signet ring cell and mucinous adenocarcinoma of colon: retrospective analysis of VACCR database.

Authors:  Ramya Thota; Xiang Fang; Shanmuga Subbiah
Journal:  J Gastrointest Oncol       Date:  2014-02

8.  Associations among histological characteristics and patient outcomes in colorectal carcinoma with a mucinous component.

Authors:  Raul S Gonzalez; Justin M M Cates; Kay Washington
Journal:  Histopathology       Date:  2018-11-11       Impact factor: 5.087

9.  "Mucin"-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases.

Authors:  Kristyna Pivovarcikova; Kvetoslava Peckova; Petr Martinek; Delia Perez Montiel; Kristyna Kalusova; Tomas Pitra; Milan Hora; Faruk Skenderi; Monika Ulamec; Ondrej Daum; Pavla Rotterova; Ondrej Ondic; Magdalena Dubova; Romuald Curik; Ana Dunatov; Tomas Svoboda; Michal Michal; Ondrej Hes
Journal:  Virchows Arch       Date:  2016-04-12       Impact factor: 4.064

10.  Colorectal Cancer Prognosis: The Impact of Signet Ring Cell.

Authors:  Refik Bademci; Jesus Bollo; M Carmen Martinez; Maria Pilar Hernadez; Eduardo Maria Targarona
Journal:  Gastrointest Tumors       Date:  2019-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.